Genome Engineering Market 2022| Worldwide Share, Global Trends, Boost Growth, Fuel Demand by 2030

The global genome engineering market for the historical period 2017–2018 and forecast period 2019–2027, increased funding in genomic research, technological developments, rising demand for synthetic genes, and investment by pharmaceutical companies for new product development are projected to drive the global genome engineering market during the forecast period

According to the report, the global genome engineering market was valued at US$ 3,685.4 Mn in 2018 and is anticipated to expand at a CAGR of 10.9% from 2019 to 2030

Get the sample copy of report@ https://qyresearchmedical.com/sample/111656

Increased Funding In Genomic Research: Key Drivers

Synthetic biology received funding of US$ 430 Mn in the U.S. from 2005 to 2010, which was much higher than US$ 160 Mn in Europe during the same period. The U.K. contributed around US$ 30 Mn. About 4% and 2% funding in the U.S. and Europe, respectively, was spent to explore ethical, social, and legal implications (ELSI) of synthetic biology. Government initiatives are on par with private investments.

More than $700 million was spent on synthetic biology research, by Department of Energy (DOE). While NIH awarded a grant of $40 million for the same.

Universities across the globe have provided significant funding for research in synthetic biology. For instance, in 2008, three Dutch universities — Delft University of Technology (Department of Bionanoscience), University of Groningen (Centre for Synthetic Biology), and the Eindhoven University of Technology (Institute for Complex Molecular Systems) — declared they would invest around USD $90 million in synthetic biology research for a period of 5 years to 10 years.

Application of genome engineering in animals has increased significantly in the past few years. Usage of this technology brings with it ethical issues that relate to animal welfare.

Investment by Pharmaceutical Companies for Developing New Treatments Boost Market Growth

Pharmaceutical firms have realized the new trends of treating genetic diseases by gene editing technologies. They are collaborating with gene editing companies to develop treatment option.

In December 2015, Bayer and CRISPR Therapeutics AG formed a joint agreement, to develop new technology to cure blindness, blood disorders, and congenital heart disease.  Bayer would be utilizing the CRISPR-Cas9 gene editing technology and would use its protein-engineering technology for the same. Bayer will contribute a minimum of USD 300 million in R&D investments in this joint venture.

View full report@ https://qyresearchmedical.com/report/genome-engineering-market-global-industry-analysis-size-share-growth-trends-and-forecast-2019-2030/111656

In January 2015, Novartis formed a collaboration with Intellia and Caribou, which would help Novartis to use CRISPR genome editing technology to engineer chimeric antigen receptor (CAR) T cells and hematopoietic stem cells and also to discover and develop other medicine. This collaboration received an undisclosed amount from Novartis and USD $15 million from both Intellia and Caribou.

 Stringent Regulatory Framework to Hamper Market

There are various regulatory frameworks for genetically modifying plant genome. Process based regulatory frameworks consider the techniques used to create new crop plant varieties. The regulation is triggered when the plant is developed by using recombinant DNA technology. The definitions and guidelines for regulation was decided by the organizations such as the United Nations Food and Agricultural Organization and treaties such as the Cartagena protocol. The regulation is followed in Europe, Argentina, Brazil, and several other regions. The product based regulatory framework that prevails in the U.S. and Canada primarily focuses on the inherent risk of the final product, rather than the technology used to make it.

Global Genome engineering Market: Competitive Landscape

This report profiles major players in the global genome engineering market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111656/2900

The major players operating in the global genome engineering market are

  • Applied Stem Cell, Inc.
  • GenScript
  • Horizon Discovery Group plc
  • Integrated DNA Technologies, Inc.
  • Lonza Group Ltd.
  • New England Biolabs
  • OriGene Technologies, Inc.
  • Sangamo BioSciences, Inc.
  • Sigma-Aldrich Co. LLC.
  • Thermo Fisher Scientific, Inc.,
  • Transposagen Biopharmaceuticals, Inc.

Key Questions Answered in Global Genome engineering Market Report

  • What is the scope of growth of product companies in the global genome engineering market?
  • What will be the Y-o-Y growth of the global genome engineering market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global genome engineering market?
  • Will North America continue to be the most profitable market for genome engineering providers?
  • Which factors are anticipated to hamper the growth of the global genome engineering market during the forecast period?
  • Which are the leading companies in the global genome engineering market?

Global Genome engineering Market – Segmentation

Technology

  • Clustered regularly interspaced short palindromic repeats (CRISPR)
  • Transcription activator-like effector nuclease (Talen)
  • Zinc Finger Nuclease (ZFN)
  • Other Technologies

Application

  • Cell Line Engineering
  • Animal Genome Engineering
  • Plant Genome Engineering
  • Other Application

End-user

  • Pharmaceutical and Biotechnology Companies
  • Academics
  • Clinical Research Organizations

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Genome Engineering Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Genome Engineering Market Analysis and Forecasts, 2018–2030

5. Key Insights

5.1. Technological Advancements

5.2. Healthcare Industry Overview

6. Global Genome Engineering Market Analysis and Forecasts, By Technology

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value  Forecast By Technology, 2018–2030

6.3.1. Clustered regularly interspaced short palindromic repeats (CRISPR)

6.3.2. Transcription activator-like effector nuclease (Talen)

6.3.3. Zinc Finger Nuclease (ZFN)

6.3.4. Others

6.4. Market Attractiveness By Technology

7. Global Genome Engineering Market Analysis and Forecasts, By Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value  Forecast By Application, 2018–2030

7.3.1. Cell Line Engineering

7.3.2. Animal Genome Engineering

7.3.3. Plant Genome Engineering

7.3.4. Others

7.4. Market Attractiveness By Application

8. Global Genome Engineering Market Analysis and Forecasts, By End-user

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111656/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi